2 studies found for:    12501224 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
Condition: Phenylalanine Hydroxylase Deficiencies
Intervention: Drug: tetrahydrobiopterin (BH4)
2 Completed
Has Results
Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
Condition: Phenylketonuria
Intervention: Drug: Kuvan®

Indicates status has not been verified in more than two years